{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:16:31Z","timestamp":1775708191598,"version":"3.50.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.clgc.2015.03.006","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T18:32:52Z","timestamp":1428258772000},"page":"295-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Hypoxia and Prostate Cancer Aggressiveness: A\u00a0Tale With Many Endings"],"prefix":"10.1016","volume":"13","author":[{"given":"Avelino","family":"Fraga","sequence":"first","affiliation":[]},{"given":"Ricardo","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Pr\u00edncipe","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"suppl 5","key":"10.1016\/j.clgc.2015.03.006_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/theoncologist.9-90005-10","article-title":"The role of hypoxia-induced factors in tumor progression","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.clgc.2015.03.006_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0093-7754(01)90210-6","article-title":"Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy","volume":"28","author":"Vaupel","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clgc.2015.03.006_bib3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00000421-200110000-00009","article-title":"Hypoxia in human prostate carcinoma: an Eppendorf PO2 study","volume":"24","author":"Movsas","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clgc.2015.03.006_bib4","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hed.20223","article-title":"Hypoxia in head and neck cancer: how much, how important?","volume":"27","author":"Janssen","year":"2005","journal-title":"Head Neck"},{"key":"10.1016\/j.clgc.2015.03.006_bib5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0210-4806(09)72891-8","volume":"33","author":"Fraga","year":"2009","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.clgc.2015.03.006_bib6","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1073\/pnas.85.24.9533","article-title":"Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells","volume":"85","author":"Young","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clgc.2015.03.006_bib7","doi-asserted-by":"crossref","first-page":"35730","DOI":"10.1074\/jbc.M204529200","article-title":"Oxygen-mediated regulation of tumor cell invasiveness. Involvement of a nitric oxide signaling pathway","volume":"277","author":"Postovit","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clgc.2015.03.006_bib8","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2007.12.7878","article-title":"Hypoxic radiosensitization: adored and ignored","volume":"25","author":"Overgaard","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2015.03.006_bib9","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1038\/sj.onc.1206703","article-title":"Investigating hypoxic tumor physiology through gene expression patterns","volume":"22","author":"Denko","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.clgc.2015.03.006_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0074-7696(04)42004-X","article-title":"The hypoxia-inducible factor and tumor progression along the angiogenic pathway","volume":"242","author":"Brahimi-Horn","year":"2005","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.clgc.2015.03.006_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G","article-title":"Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma","volume":"42","author":"Gupta","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.clgc.2015.03.006_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1464-410x.2001.02231.x","article-title":"Inducible nitric oxide synthase expression in benign prostatic hyperplasia, low- and high-grade prostatic intraepithelial neoplasia and prostatic carcinoma","volume":"88","author":"Baltaci","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2015.03.006_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0076-6879(07)35024-6","article-title":"Hypoxia-inducible factor-1alpha under the control of nitric oxide","volume":"435","author":"Brune","year":"2007","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.clgc.2015.03.006_bib14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature04871","article-title":"Hypoxia signalling in cancer and approaches to enforce tumour regression","volume":"441","author":"Pouyssegur","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.clgc.2015.03.006_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia\u2014a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clgc.2015.03.006_bib16","doi-asserted-by":"crossref","first-page":"6683","DOI":"10.1158\/0008-5472.CAN-06-0425","article-title":"Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia","volume":"66","author":"Kaidi","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.clgc.2015.03.006_bib17","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1158\/1055-9965.EPI-08-1148","article-title":"Established prostate cancer susceptibility variants are not associated with disease outcome","volume":"18","author":"Wiklund","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clgc.2015.03.006_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejca.2013.09.001","article-title":"The HIF1A functional genetic polymorphism at locus\u00a0+1772 associates with progression to metastatic prostate cancer and refractoriness to hormonal castration","volume":"50","author":"Fraga","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2015.03.006_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1470-2045(08)70076-7","article-title":"Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study","volume":"9","author":"Vergis","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clgc.2015.03.006_bib20","first-page":"1561","article-title":"Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score","volume":"20","author":"Stewart","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.clgc.2015.03.006_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1196\/annals.1397.007","article-title":"Significant coexpression of GLUT-1, Bcl-xL, and Bax in colorectal cancer","volume":"1095","author":"Wincewicz","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clgc.2015.03.006_bib22","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nature04695","article-title":"Lysyl oxidase is essential for hypoxia-induced metastasis","volume":"440","author":"Erler","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.clgc.2015.03.006_bib23","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1158\/0008-5472.CAN-04-4480","article-title":"Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors","volume":"65","author":"Sobhanifar","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.clgc.2015.03.006_bib24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.radonc.2007.04.028","article-title":"Hypoxia induced expression of endogenous markers in\u00a0vitro is highly influenced by pH","volume":"83","author":"Sorensen","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clgc.2015.03.006_bib25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clgc.2015.03.006_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cdp.2003.12.009","article-title":"Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis","volume":"28","author":"Zhong","year":"2004","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.clgc.2015.03.006_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2004.09.026","article-title":"Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis","volume":"6","author":"Tang","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.clgc.2015.03.006_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc2868","article-title":"Targeting the tumour vasculature: insights from physiological angiogenesis","volume":"10","author":"Chung","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clgc.2015.03.006_bib29","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","article-title":"Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation","volume":"23","author":"Hu","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.clgc.2015.03.006_bib30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4161\/cc.6.8.4133","article-title":"Hypoxia inducible factor-2alpha in cancer","volume":"6","author":"Lofstedt","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.clgc.2015.03.006_bib31","first-page":"1","article-title":"The HIF-2alpha-driven pseudo-hypoxic phenotype in tumor aggressiveness, differentiation, and vascularization","volume":"345","author":"Pietras","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.clgc.2015.03.006_bib32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/pros.20594","article-title":"Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands","volume":"67","author":"Monsef","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.clgc.2015.03.006_bib33","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.1158\/1078-0432.CCR-05-0460","article-title":"The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer","volume":"11","author":"Boddy","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2015.03.006_bib34","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1073\/pnas.94.11.5667","article-title":"Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor","volume":"94","author":"Kallio","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clgc.2015.03.006_bib35","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/pros.21204","article-title":"The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes","volume":"70","author":"Mori","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.clgc.2015.03.006_bib36","first-page":"688","article-title":"Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts","volume":"165","author":"Stewart","year":"2001","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2015.03.006_bib37","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target","volume":"438","author":"Ferrara","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.clgc.2015.03.006_bib38","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1093\/emboj\/19.15.4064","article-title":"A\u00a0repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3\u2032-kinase activation and endothelial cell migration","volume":"19","author":"Gille","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.clgc.2015.03.006_bib39","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1172\/JCI200318181","article-title":"HIF hydroxylation and the mammalian oxygen-sensing pathway","volume":"111","author":"Safran","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clgc.2015.03.006_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1748-717X-7-66","article-title":"The prognostic value of expression of HIF1alpha, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy","volume":"7","author":"Weber","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clgc.2015.03.006_bib41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/pros.10321","article-title":"Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate","volume":"58","author":"Li","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.clgc.2015.03.006_bib42","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clgc.2015.03.006_bib43","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1096\/fj.01-0944rev","article-title":"Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression","volume":"16","author":"Wenger","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.clgc.2015.03.006_bib44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.clgc.2015.03.006_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.clgc.2015.03.006_bib46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4161\/cc.3.2.618","article-title":"Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target","volume":"3","author":"Potter","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.clgc.2015.03.006_bib47","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.clgc.2015.03.006_bib48","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64038-2","article-title":"Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer","volume":"158","author":"Ivanov","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clgc.2015.03.006_bib49","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/sj.bjc.6602828","article-title":"Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer","volume":"93","author":"Van den Eynden","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2015.03.006_bib50","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/002215549804600409","article-title":"Immunohistochemistry of carbonic anhydrase isozyme IX (MN\/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity","volume":"46","author":"Saarnio","year":"1998","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1016\/j.clgc.2015.03.006_bib51","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0002-9440(10)64048-5","article-title":"Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast","volume":"158","author":"Wykoff","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clgc.2015.03.006_bib52","first-page":"6130","article-title":"Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia","volume":"63","author":"Sowter","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.clgc.2015.03.006_bib53","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2001.19.16.3660","article-title":"Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma","volume":"19","author":"Chia","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2015.03.006_bib54","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.bjc.6603530","article-title":"Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer","volume":"96","author":"Hussain","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2015.03.006_bib55","first-page":"677","article-title":"An investigation into the prognostic significance of necrosis and hypoxia in high grade and invasive bladder cancer","volume":"178","author":"Ord","year":"2007","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2015.03.006_bib56","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/(SICI)1097-0215(20000315)85:6<865::AID-IJC21>3.0.CO;2-Q","article-title":"Molecular cloning and immunogenicity of renal cell carcinoma\u2013associated antigen G250","volume":"85","author":"Grabmaier","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clgc.2015.03.006_bib57","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1200\/JCO.2003.11.132","article-title":"Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non\u2013small-cell lung cancer","volume":"21","author":"Swinson","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2015.03.006_bib58","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/ijc.22436","article-title":"HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome","volume":"120","author":"Trastour","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clgc.2015.03.006_bib59","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.bbrc.2009.06.064","article-title":"Antibody-specific detection of CAIX in breast and prostate cancers","volume":"386","author":"Li","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clgc.2015.03.006_bib60","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tips.2006.09.002","article-title":"Targeting tumor-associated carbonic anhydrase IX in cancer therapy","volume":"27","author":"Thiry","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.clgc.2015.03.006_bib61","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.clgc.2015.03.006_bib62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/scbi.1995.0017","article-title":"Involvement of extracellular matrix constituents in breast cancer","volume":"6","author":"Lochter","year":"1995","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.clgc.2015.03.006_bib63","first-page":"10","article-title":"Molecular insights into prostate cancer\u00a0progression: the missing link of tumor microenvironment","volume":"173","author":"Chung","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2015.03.006_bib64","first-page":"2912","article-title":"Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling","volume":"8","author":"Tuxhorn","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2015.03.006_bib65","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/cncr.11181","article-title":"Stromal factors involved in prostate carcinoma metastasis to bone","volume":"97","author":"Cooper","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2015.03.006_bib66","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1158\/0008-5472.CAN-06-3197","article-title":"Lysyl oxidase mediates hypoxic control of metastasis","volume":"66","author":"Erler","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.clgc.2015.03.006_bib67","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1593\/neo.10344","article-title":"Hypoxic tumor microenvironments reduce collagen I fiber density","volume":"12","author":"Kakkad","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.clgc.2015.03.006_bib68","first-page":"11","article-title":"Collagen fibers in human prostatic lesions: histochemistry and anisotropies","volume":"35","author":"Taboga","year":"2003","journal-title":"J\u00a0Submicrosc Cytol Pathol"},{"key":"10.1016\/j.clgc.2015.03.006_bib69","first-page":"207","article-title":"Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate","volume":"10","author":"Zhang","year":"2003","journal-title":"Oncol Rep"},{"key":"10.1016\/j.clgc.2015.03.006_bib70","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1371\/journal.pmed.0030047","article-title":"Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers","volume":"3","author":"Chi","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.clgc.2015.03.006_bib71","doi-asserted-by":"crossref","first-page":"18892","DOI":"10.1073\/pnas.1004952107","article-title":"LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling","volume":"107","author":"Gao","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clgc.2015.03.006_bib72","first-page":"4478","article-title":"A\u00a0molecular role for lysyl oxidase in breast cancer invasion","volume":"62","author":"Kirschmann","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.clgc.2015.03.006_bib73","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1038\/onc.2009.203","article-title":"Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling","volume":"28","author":"Palamakumbura","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.clgc.2015.03.006_bib74","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1046\/j.1432-1033.2003.03846.x","article-title":"Oxygen tension regulates the expression of a group of procollagen hydroxylases","volume":"270","author":"Hofbauer","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.clgc.2015.03.006_bib75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12307-012-0105-z","article-title":"Lysyl oxidase, extracellular matrix remodeling and cancer metastasis","volume":"5","author":"Xiao","year":"2012","journal-title":"Cancer Microenviron"},{"key":"10.1016\/j.clgc.2015.03.006_bib76","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1158\/1055-9965.EPI-04-0490","article-title":"The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer","volume":"14","author":"Li","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clgc.2015.03.006_bib77","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1073\/pnas.0802047105","article-title":"Notch signaling mediates hypoxia-induced tumor cell migration and invasion","volume":"105","author":"Sahlgren","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clgc.2015.03.006_bib78","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1074\/jbc.M109.042424","article-title":"The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1","volume":"285","author":"Schietke","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clgc.2015.03.006_bib79","first-page":"3810","article-title":"Hypoxia promotes fibrogenesis in\u00a0vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition","volume":"117","author":"Higgins","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clgc.2015.03.006_bib80","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/jcb.10413","article-title":"Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell","volume":"88","author":"Kagan","year":"2003","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.clgc.2015.03.006_bib81","doi-asserted-by":"crossref","first-page":"22537","DOI":"10.1074\/jbc.M102352200","article-title":"Multiple bone morphogenetic protein 1\u2013related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures","volume":"276","author":"Uzel","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clgc.2015.03.006_bib82","first-page":"1285","article-title":"Reduced lysyl oxidase messenger RNA levels in experimental and human prostate cancer","volume":"58","author":"Ren","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.clgc.2015.03.006_bib83","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bbamcr.2009.04.013","article-title":"Tumor suppressive effect of lysyl oxidase proenzyme","volume":"1793","author":"Contente","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clgc.2015.03.006_bib84","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1158\/0008-5472.CAN-06-3867","article-title":"The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2\/neu-driven breast cancer","volume":"67","author":"Min","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.clgc.2015.03.006_bib85","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1158\/0008-5472.CAN-07-0776","article-title":"Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells","volume":"67","author":"Wu","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.clgc.2015.03.006_bib86","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1200\/JCO.2008.20.6003","article-title":"Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03","volume":"27","author":"Le","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2015.03.006_bib87","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.amjsurg.2004.11.031","article-title":"Lysyl oxidase expression in bronchogenic carcinoma","volume":"189","author":"Woznick","year":"2005","journal-title":"Am J Surg"},{"key":"10.1016\/j.clgc.2015.03.006_bib88","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1741-7015-6-11","article-title":"Collagen density promotes mammary tumor initiation and progression","volume":"6","author":"Provenzano","year":"2008","journal-title":"BMC Med"},{"key":"10.1016\/j.clgc.2015.03.006_bib89","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1182\/blood-2010-10-313296","article-title":"Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane","volume":"118","author":"Bignon","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clgc.2015.03.006_bib90","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm.2208","article-title":"Allosteric inhibition of lysyl oxidase\u2013like-2 impedes the development of a pathologic microenvironment","volume":"16","author":"Barry-Hamilton","year":"2010","journal-title":"Nat Med"},{"issue":"5 suppl","key":"10.1016\/j.clgc.2015.03.006_bib91","article-title":"Genome-wide association study (GWAS) of efficacy and safety endpoints in pazopanib- or sunitinib-treated patients with renal cell carcinoma (RCC)","volume":"32","author":"Johnson","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2015.03.006_bib92","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4161\/cbt.5.8.3230","article-title":"Lysyl oxidase (LOX) and hypoxia-induced metastases","volume":"5","author":"Sion","year":"2006","journal-title":"Cancer Biol Ther"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767315000713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767315000713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:24:04Z","timestamp":1761564244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767315000713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1558767315000713"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2015.03.006","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia and Prostate Cancer Aggressiveness: A\u00a0Tale With Many Endings","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2015.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}